Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole on Endometrial Thickness in Premenopausal Women
NCT00467493Phase 2Completed
- Sponsor
- Meditrina Pharmaceuticals
- Start
- Mar 2007
- Primary completion
- Sep 2007
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of anastrozole in menstrual disorders (6 arms), sponsored by Meditrina Pharmaceuticals. Primary endpoints: Endometrial thickness and Safety. Started Mar 2007; status: completed.
02
Drugs
anastrozole
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on NCT00467493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467493.